Development of a comorbidity index for use in obstetric patients

BT Bateman, JM Mhyre, S Hernandez-Diaz… - Obstetrics & …, 2013 - journals.lww.com
OBJECTIVE: To develop and validate a maternal comorbidity index to predict severe
maternal morbidity, defined as the occurrence of acute maternal end-organ injury, or …

Propensity score methodology for confounding control in health care utilization databases

E Patorno, A Grotta, R Bellocco… - … , Biostatistics, and Public …, 2013 - riviste.unimi.it
Propensity score (PS) methodology is a common approach to control for confounding in
nonexperimental studies of treatment effects using health care utilization databases. This …

Development and validation of a Multidimensional Prognostic Index for mortality based on a standardized Multidimensional Assessment Schedule (MPI-SVaMA) in …

A Pilotto, P Gallina, A Fontana, D Sancarlo… - Journal of the American …, 2013 - Elsevier
OBJECTIVES: To develop and validate a Multidimensional Prognostic Index (MPI) for
mortality based on information collected by the Multidimensional Assessment Schedule …

Improved prediction of medical expenditures and health care utilization using an updated chronic disease score and claims data

CA Huber, S Schneeweiss, A Signorell… - Journal of clinical …, 2013 - Elsevier
Objective To predict future medical expenditures, health care utilization, and mortality in
Switzerland using an updated chronic disease score (CDS), a chronic morbidity measure …

Clinical and health care use characteristics of patients newly starting allopurinol, febuxostat, and colchicine for the treatment of gout

SC Kim, BMW Schmidt, JM Franklin, J Liu… - Arthritis care & …, 2013 - Wiley Online Library
Objective Gout is a common form of inflammatory arthritis with an increasing prevalence in
developed countries. It is well known that many patients with gout have significant …

[HTML][HTML] Treatment dynamics of newly marketed drugs and implications for comparative effectiveness research

JJ Gagne, K Bykov, RJ Willke, KH Kahler, P Subedi… - Value in health, 2013 - Elsevier
Objectives Clinicians and payers require rapid comparative effectiveness (CE) evidence
generation to inform decisions for new drugs. We empirically assessed treatment dynamics …

Development and validation of a pharmacy‐based comorbidity measure in a population‐based automated health care database

YH Dong, CH Chang, WY Shau, RN Kuo… - … : The Journal of …, 2013 - Wiley Online Library
Study Objective To develop the Pharmacy‐Based Disease Indicator (PBDI), and to evaluate
its performance versus the diagnosis‐based Deyo version of the Charlson Index in …

Predictive performance of comorbidity measures in administrative databases for diabetes cohorts

LM Lix, J Quail, O Fadahunsi, GF Teare - BMC Health Services Research, 2013 - Springer
Background The performance of comorbidity measures for predicting mortality in chronic
disease populations and using ICD-9 diagnosis codes in administrative health data has …

Time until incident dementia among Medicare beneficiaries using centrally acting or non‐centrally acting ACE inhibitors

PL Hebert, AM McBean, H O'Connor… - … and drug safety, 2013 - Wiley Online Library
Background Centrally active (CA) angiotensin‐converting enzyme inhibitors (ACEIs) are
able to cross the blood–brain barrier. Small observational studies and mouse models …

Patterns and predictors of generic narrow therapeutic index drug use among older adults

JJ Gagne, JM Polinski, AS Kesselheim… - Journal of the …, 2013 - Wiley Online Library
Objectives To ascertain predictors of initiation of brand‐name versus generic narrow
therapeutic index (NTI) drugs. Design Retrospective cohort study. Setting Data from CVS C …